A trader monitors financial data on computer screens on the trading floor at ETX Capital, a broker of contracts-for-difference, during U.K. parliamentary voting on amendments for the Brexit deal in London, U.K. (Photographer: Simon Dawson/Bloomberg)
5 years ago
Apr 27, 2021
The S&P BSE Sensex climbed 1.17% to 48,954.16 while the NSE Nifty 50 index gained 1.16% to 14,653.05. All 19 sector sub-indices compiled by BSE Ltd. advanced, led by a gauge of metal companies.
A panel of the bank’s central board will meet April 28 to examine the status and decide on fundraising of as much as $2 billion via bonds, the State Bank of India said in a stock exchange filing.
The fund raising in 2021-22 can be in a single or multiple tranches and via a public or private placement of senior notes in U.S. dollar or any other convertible currency
Maruti Suzuki India Ltd.’s profit narrowed and earnings trailed estimates as a resurgent Covid-19 outbreak hit consumer demand in Asia’s third-largest economy.
Net income fell 9.3% to Rs 1,166 crore ($157 million) in the three months ended March 31, the unit of Japan’s Suzuki Motor Corp. said in a statement Tuesday. That’s less than the average analyst estimate of Rs 1,699 crore, according to data compiled by Bloomberg.
Revenue at Maruti Suzuki for the fourth quarter rose 32% year-on-year to Rs 24,113 crore.
Maintains ‘outperform’ rating, raises target price from Rs 765 to Rs780.
HDFC Life has demonstrated industry-leading growth with a 17 % CAGR during FY19-21 vs private peers' growth of 9% CAGR, driven by margin-accretive product innovations in its long-term savings business
Expect HDFC Life to deliver a 19 % VNB CAGR in FY21-23 and while valuations are not cheap, it remains a steady compounder.
The company balanced its product mix, with the share of non-annuity non-PAR savings book down and a share of PAR up.
Protection book continues to be impacted by supply-side challenges
Moderation in spend is not a big concern in an uncertain environment.
NIM has been supported by lower cost of debt, but lower yield was driven by lower revolver mix and RBI RE book with 15-16% interest rate
Incremental credit cost in Q4 was largely inline
Maintain 'Buy' with a target price of Rs 1,205
Motilal Oswal
Expect spends to pick up as retail spends have exceeded pre-Covid levels and corporate spends are also back at pre-Covid levels.
Estimate a loan book/earnings CAGR of 24%/60% over FY21-23E -- as a strong PCR of around 78%, coupled with additional management overlay provisions of Rs 297 crore, should keep credit costs in check
Maintain ‘Buy’ rating with a target price of Rs 1,200
“The recent news of various countries extending help to India in the Covid fight is further boosting the sentiment,” Ajit Mishra, vice president of research at Religare Broking Ltd. wrote in a note. “We remain cautiously optimistic as volatility is likely to remain high on the back of derivative expiry and upcoming earnings announcements.”
The U.S. announced Monday it would share its entire supply of AstraZeneca Plc’s Covid-19 vaccine with other countries and readied an aid package for India, as President Joe Biden pivots to ramp up U.S. pandemic assistance to the rest of the world.